Here we sought to address this by studying the putative role of the protective axis of the RAS, by focusing on ACE2, AT2R and Mas, in a mouse model of diabetic nephropathy treated with increasing doses of candesartan, from intermediate (1 mg/kg/d) to ultra-high doses (75 mg/kg/d). Here, MAS1 is linked to diabetic kidney disease.